Quantitative Whole-Body Autoradiographic Determination of Tacrine Tissue Distribution in Rats Following Intravenous or Oral Dose
- 1 January 1989
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 06 (11) , 924-932
- https://doi.org/10.1023/a:1015933210803
Abstract
Tacrine (l,2,3,4-tetrahydro-9-acridinamine) has been employed in diverse clinical situations but has recently been of considerable interest for the treatment of cognitive deficits associated with senile dementia (Alzheimer's disease). The present studies examined tissue distribution of radiolabeled tacrine by quantitative whole-body autoradiography. Tacrine radioequivalents were widely distributed to tissue following iv or peroral dose, with an apparently prolonged absorption phase following po dose. The presence of high levels of activity in kidneys and ureters indicates a major role for urinary excretion, but there is also evidence for biliary excretion and direct secretion of compound or metabolites into the intestinal lumen. Tacrine was rapidly taken up into the brain and demonstrated regional localization to cortex, hippocampus, thalamus, and striatum. Although the inhibition of acetylcholinesterase by tacrine is well documented, regional uptake in brain did not correlate consistently with distribution of the enzyme, supporting suggestions by others that the alleged action of tacrine in treatment of senile dementia may be by mechanisms other than cholinesterase inhibition.This publication has 17 references indexed in Scilit:
- Further analysis of the neuropharmacological profile of 9-amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's diseaseLife Sciences, 1988
- 9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ currentEuropean Journal of Pharmacology, 1987
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- Oral physostigmine and lecithin improve memory in Alzheimer diseaseAnnals of Neurology, 1983
- THA—A Review of the Literature and Its Use in Treatment of Five Overdose PatientsClinical Toxicology, 1980
- Pain Sensitivity in SchizophrenicsNew England Journal of Medicine, 1979
- TETRAHYDROAMINACRINE IN ANAESTHESIABritish Journal of Anaesthesia, 1965
- Estimation and Urinary Excretion of TetrahydroaminoacrxdineJournal of Pharmacy and Pharmacology, 1962
- THE PHARMACOLOGY OF SOME NEW ANTI‐CHOLINESTERASESImmunology & Cell Biology, 1953
- SOME ASPECTS OF THE PHARMACOLOGY OF MORPHINE, WITH SPECIAL REFERENCE TO ITS ANTAGONISM BY 5–AMINO–ACRIDINE AND OTHER CHEMICALLY RELATED COMPOUNDSThe Medical Journal of Australia, 1949